The dedicated members of our Board of Directors actively participate in the governance of Breastcancer.org by contributing to the strategic planning and the financial management of the organization. The Breastcancer.org Board of Directors represents diverse areas of business, philanthropy, media, and communications. They are all committed to fulfilling our mission to help people make sense of the complex medical and personal information about breast health and breast cancer, so they can make the best decisions for their lives.
Mike DeLone is a principal in Deloitte Consulting LLP and the national sector leader for Deloitte’s Life Sciences practice. He leads a multi-disciplinary team that serves clients in the pharmaceutical, biotechnology, medical technology, and consumer healthcare segments through consulting, advisory, audit, and tax services. In his role as a life sciences consulting leader, Mike is responsible for the overall strategic direction of the life sciences practice as well as its go-to-market strategies and resources.
Joseph Evangelisti is head of Worldwide Corporate Communications and Media Relations for J.P. Morgan Chase. In this role, he serves as chief communications officer, lead spokesman, and head internal communications for the firm.
Bruce G. Fischer is a senior executive with a solid financial background and extensive experience in all facets of refining and chemical industries, as well as the healthcare industry. He has significant turnaround knowledge with experience in strategic planning, mergers and acquisitions, and business development. He was chairman of Crozer-Keystone Health System, a billion-dollar nonprofit health system.
Nancy Frandsen is a trademark attorney, guiding clients through the core areas of trademark and copyright strategic counseling and portfolio management, as well as through enforcement before the federal courts and the Trademark Trial and Appeal Board (TTAB). Nancy is a Philadelphia Chapter Founder and Leader of ChIPs, a national organization advancing women in tech, law and policy.
Carl Fremont is CEO at Quigley-Simpson, where he oversees management of all aspects of the firm, including strategic direction, with a focus on expanding the firm's data and analytics practice. He has a diverse background in consumer behavior, data and technology. A leading industry player, Carl is frequently sought out and quoted in the press on his views on the future of marketing and media.
Richy Glassberg is co-founder/CEO of SafeGuard GDPR, with over two decades of experience across a wide range of data privacy compliance, digital advertising, sales, and operations disciplines. He is the founding chairman of the annual NYC Bowling for Breastcancer.org event, which has raised over $4.5M since its inception in 2010.
Susan Hertzberg has held executive positions at Quest Diagnostics, Abbott Diagnostics, and Oxford Health Plans, most recently as president and chief executive officer of Boston Heart Diagnostics, where her visionary leadership guided the product development, market strategy, and overall execution of the company.
Jane Holmes Hollingsworth, board chair, is managing partner of Militia Hill Ventures, a business focused on building and growing high quality life sciences companies, and executive chair of Talee Bio. She is also former executive chair of Immunome Inc., a cancer immunotherapy company, and co-founder and former CEO of NuPathe Inc., a publicly traded biopharmaceutical company.
Jerry L. Johnson is president and CEO of Axum Advisors, LLC, a business advisory/consulting firm for start-ups, middle market businesses, professional service firms, and government agencies. Over the past 45 years, he has held senior management positions in several industry sectors including 20 years in telecommunications and 25 years in venture capital and finance. Deeply committed to serving many communities, Mr. Johnson has chaired several large nonprofits and currently serves on Boards of several private and public companies.
Jean Kane is an attorney with over 25 years of leadership experience in private sector, government, nonprofit, school, and community organizations. After a successful legal career focused on environmental law, she turned her attention to working with and for nonprofit and community organizations.
David Kopp is an experienced chief executive in consumer digital health with expertise spanning strategy, product development, marketing, and technology. Most recently, David led a passionate and highly successful team at Healthline Media, spearheading global growth to reach more visitors than any other health publisher. He brings deep expertise in growing and managing major companies, consumer-centric digital platforms, ad monetization, and bio-pharma advertising.
Kim Kubek, M.D., is a diagnostic radiologist specializing in breast imaging. She has her own practice outside of Philadelphia, where she currently sees approximately 5,000 women a year. Kim works closely with her patients to ensure they get rapid follow-up care as needed.
Alice Limkakeng has spent nearly 25 years building healthcare companies as a venture/growth equity investor and senior executive. She is currently CEO of SleepArchiTx. She was previously Chief Business Officer of Boston Heart Diagnostics and, earlier in her career, a senior investor at Bain Capital Ventures, where she worked closely with healthcare entrepreneurs to build leading-edge businesses and collective transactions valued over $1B. She has also served as a strategic advisor to PatientsLikeMe.
Donna-Marie Manasseh, M.D., is the chief of breast surgery at the Maimonides Breast Cancer Center in Brooklyn, NY. Dr. Manasseh is a strong advocate of empowering women by educating them about breast health and disease. She has published several chapters on breast disease, has co-authored a textbook relating to breast disease and evaluation, and is the recipient of several awards.
Lisa B. Petkun is a partner at Troutman Pepper, working on behalf of individuals, partnerships, nonprofit organizations and corporations, handling sophisticated tax planning needs associated with complex business and financial structures. She counsels nonprofit organizations on a wide range of issues, including forms 990 and 990-PF compliance and state charitable solicitation and registration laws.
Marisa Weiss, M.D., chief medical officer and founder, is regarded as a visionary advocate for her innovative and steadfast approach to informing individuals to protect their breast health and overcome the challenges of breast cancer. Dr. Weiss currently practices at Lankenau Medical Center, where she serves as director of breast radiation oncology and director of breast health outreach. Learn more about Dr. Weiss.
Hope Wohl, CEO, has played a pivotal role in the continual reshaping of Breastcancer.org’s approach to patient engagement in an ever-changing landscape of science, technology, consumer behavior, and healthcare. Since 2000, her leadership has grown Breastcancer.org from an early Internet start-up to the leading digital resource for breast cancer information and peer support.